(CSBR) |
| 0 (0%) 08-28 08:51 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 6.48 |
| Resistance 1: | 5.85 |
| Pivot price: | 5.03 |
| Support 1: | 4.83 |
| Support 2: | 4.02 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.080 |
| Book Value | 0.280 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.053 |
| Profit Margin (%) | -1.98 |
| Operating Margin (%) | -3.77 |
| Return on Assets (ttm) | -2.2 |
| Return on Equity (ttm) | -30.0 |
Company news
Sun, 23 Aug 2026
Champions (CSBR) Earnings Update: Headline Results Are Close to Consensus in the Latest Reading; Market Response: Shares Move 4.25% Lower in the Latest Session - Dividend Increase Stocks - vinanet.vn
Thu, 20 Aug 2026
Champions (CSBR) Range: Finishes 4.86% Up at $5.18 in the Latest Session; Price Setup: the Near-Term Reference Band Stretches From $4.92 to $5.44 in the Available Record - Descending Triangle - dars.gov.et
Sun, 16 Aug 2026
Precision Trading with Champions Oncology Inc. (CSBR) Risk Zones - Stock Traders Daily
Thu, 06 Aug 2026
Technical Reactions to CSBR Trends in Macro Strategies - Stock Traders Daily
Thu, 30 Jul 2026
CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push - Yahoo Finance
Mon, 27 Jul 2026
Champions Oncology Q4 2026 Earnings Call Transcript - MarketBeat
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
